PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
41.18%
Net income growth above 1.5x AXSM's 19.26%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-29.56%
Both reduce yoy D&A, with AXSM at -0.70%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
No Data
No Data available this quarter, please select a different quarter.
78.42%
SBC growth well above AXSM's 5.59%. Michael Burry would flag major dilution risk vs. competitor’s approach.
355.10%
Working capital change of 355.10% while AXSM is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might affect near-term cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
99.40%
A yoy AP increase while AXSM is negative at -56.31%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
781.33%
Growth well above AXSM's 100.00%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-0.56%
Both negative yoy, with AXSM at -19.79%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
75.47%
Operating cash flow growth above 1.5x AXSM's 25.25%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.